Hussein Abdul-Hassan Tawbi MD

Assistant Professor, Medicine, University of Pittsburgh School of Medicine

1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161

Dr. Tawbi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tawbi's full profile Already have an account?

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2005 - 2008
UPMC Medical EducationResidency, Internal Medicine, 2002 - 2005
American University of Beirut Faculty of MedicineClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
GA State Medical License 2023 - 2027
LA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
OK State Medical License 2020 - 2027
TX State Medical License 2015 - 2027
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
PA State Medical License 2002 - 2016
MI State Medical License 2007 - 2008
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2015

Clinical Trials

Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
COMPLETED
PHASE1, PHASE2
Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden
COMPLETED
Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free
COMPLETED
PHASE2

Publications & Presentations

PubMed

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Georgina V Long, Inês Pires da Silva, Kristen A Perry, Jurriaan Romano, Serigne N Lo
Nature Medicine. 2026-10-01
Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.
Jeffrey S Weinberg, Brandon S Imber, Vincent DiNapoli, Nelson S Moss, Kimberly B Hoang
Journal of Clinical Oncology. 2026-09-28
Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery.
Georgina V Long, Charlie Garnett-Benson, Sonia Dolfi, Paolo A Ascierto, Jun Guo
Future Oncology. 2026-09-22

Journal Articles

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Kim Margolin, Omid Hamid, Christopher D Lao, Anna C Pavlick, Michael A Postow, F Stephen Hodi, Nikhil I Khushalani, Marc S Ernstoff, Hussein A Tawbi, Igor Puzanov, Ahm..., The New England Journal of Medicine
Metastatic Melanoma with balloon/histiocytoid Cytomorphology After Treatment with Immunotherapy: A Histologic Mimic and Diagnostic Pitfall
Michael T Tetzlaff, Priyadharsini Nagarajan, Hussein Tawbi, Victor G Prieto, Phyu P Aung, Journal of Cutaneous Pathology

Lectures

Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204).
2019 ASCO Annual Meeting - 6/1/2019
Phase I/II study of the PI3K inhibitor GSK2636771 in combination with pembrolizumab (P) in patients (pts) with PD-1 refractory metastatic melanoma (MM) and PTEN loss.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
What to Do First in Case of Melanoma Brain Metastases and Simultaneous Extracerebral Disease
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

FDA Files Reveal Lingering Concerns, Contrasting Views Behind Replimune Melanoma NodSeptember 3rd, 2026
Replimune’s Twice-Rejected Melanoma Drug Prevails in FDA AdcommAugust 3rd, 2026
This New Vaccine Blocked Cancer in Mice. Here's Why Experts Say This Is a Major Breakthrough—and What It Means for HumansOctober 15th, 2025